Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tetsuya Hosaka

Showing results (301-310 of 306) with videos related to

Pageof 31
Sort By:
You have reached the last page of results.This site can display upto 306 results.
Internal Medicine (Tokyo, Japan)|May 18, 2011
The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver diseaseYasuji Arase, Fumitaka Suzuki, Mariko Kobayashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 16, 2013
Efficacy and safety in sitagliptin therapy for diabetes complicated by non-alcoholic fatty liver diseaseYasuji Arase, Yusuke Kawamura, Yuya Seko, et al.
Liver Cancer|February 12, 2024
A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L TrialMasatoshi Kudo, Kazuomi Ueshima, Issei Saeki, et al.
Journal of Gastroenterology|April 21, 2026
On-treatment viral factors affect subsequent hepatitis B surface antigen seroclearance in patients treated with nucleos(t)ide analogs for > 10 yearsTetsuya Hosaka, Hayato Hikita, Yuki Tahata, et al.
Clinical and Translational Gastroenterology|October 23, 2020
Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 PatientsYee Hui Yeo, Tai-Chung Tseng, Tetsuya Hosaka, et al.
Gastroenterology|October 21, 2018
Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysisYee Hui Yeo, Hsiu J Ho, Hwai-I Yang, et al.
Pageof 31

Showing results (301-310 of 306) with videos related to

Sort By:
Pageof 31
You have reached the last page of results.This site can display upto 306 results.
Internal Medicine (Tokyo, Japan)|May 18, 2011
The development of chronic kidney disease in Japanese patients with non-alcoholic fatty liver diseaseYasuji Arase, Fumitaka Suzuki, Mariko Kobayashi, et al.
Hepatology Research : the Official Journal of the Japan Society of Hepatology|March 16, 2013
Efficacy and safety in sitagliptin therapy for diabetes complicated by non-alcoholic fatty liver diseaseYasuji Arase, Yusuke Kawamura, Yuya Seko, et al.
Liver Cancer|February 12, 2024
A Phase 2, Prospective, Multicenter, Single-Arm Trial of Transarterial Chemoembolization Therapy in Combination Strategy with Lenvatinib in Patients with Unresectable Intermediate-Stage Hepatocellular Carcinoma: TACTICS-L TrialMasatoshi Kudo, Kazuomi Ueshima, Issei Saeki, et al.
Journal of Gastroenterology|April 21, 2026
On-treatment viral factors affect subsequent hepatitis B surface antigen seroclearance in patients treated with nucleos(t)ide analogs for > 10 yearsTetsuya Hosaka, Hayato Hikita, Yuki Tahata, et al.
Clinical and Translational Gastroenterology|October 23, 2020
Incidence, Factors, and Patient-Level Data for Spontaneous HBsAg Seroclearance: A Cohort Study of 11,264 PatientsYee Hui Yeo, Tai-Chung Tseng, Tetsuya Hosaka, et al.
Gastroenterology|October 21, 2018
Factors Associated With Rates of HBsAg Seroclearance in Adults With Chronic HBV Infection: A Systematic Review and Meta-analysisYee Hui Yeo, Hsiu J Ho, Hwai-I Yang, et al.
Pageof 31